IRIS
SANTILLI, FRANCESCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.730
EU - Europa 4.840
AS - Asia 3.127
SA - Sud America 221
Continente sconosciuto - Info sul continente non disponibili 15
AF - Africa 13
OC - Oceania 4
Totale 13.950
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.693
SG - Singapore 1.185
CN - Cina 990
IE - Irlanda 947
IT - Italia 803
UA - Ucraina 777
TR - Turchia 668
SE - Svezia 666
GB - Regno Unito 453
FR - Francia 365
DE - Germania 316
FI - Finlandia 211
BR - Brasile 196
IN - India 181
RU - Federazione Russa 159
NL - Olanda 30
HK - Hong Kong 29
CA - Canada 26
AT - Austria 25
PL - Polonia 19
VN - Vietnam 18
BE - Belgio 16
CZ - Repubblica Ceca 16
AR - Argentina 11
EU - Europa 11
IR - Iran 8
AL - Albania 7
IQ - Iraq 7
JP - Giappone 6
RO - Romania 6
IL - Israele 5
LT - Lituania 5
AZ - Azerbaigian 4
BD - Bangladesh 4
CL - Cile 4
MA - Marocco 4
MX - Messico 4
UZ - Uzbekistan 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AU - Australia 3
BZ - Belize 3
CH - Svizzera 3
CO - Colombia 3
DK - Danimarca 3
GR - Grecia 3
HU - Ungheria 3
KE - Kenya 3
LK - Sri Lanka 3
ZA - Sudafrica 3
EC - Ecuador 2
ES - Italia 2
NG - Nigeria 2
OM - Oman 2
PK - Pakistan 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
AE - Emirati Arabi Uniti 1
CR - Costa Rica 1
EE - Estonia 1
EG - Egitto 1
ID - Indonesia 1
JM - Giamaica 1
JO - Giordania 1
KG - Kirghizistan 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LV - Lettonia 1
MT - Malta 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PE - Perù 1
PY - Paraguay 1
QA - Qatar 1
RS - Serbia 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
SY - Repubblica araba siriana 1
VE - Venezuela 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 13.950
Salva come PNG Salva come JPEG
Città #
Chandler 1.086
Jacksonville 958
Dublin 933
Singapore 876
Princeton 383
Ashburn 380
Southend 370
Izmir 335
Nanjing 235
Dearborn 205
The Dalles 193
Beijing 185
Wilmington 185
Santa Clara 169
Cambridge 159
Ann Arbor 144
Altamura 134
Chieti 104
Nanchang 99
Boardman 88
Pescara 88
New York 75
Washington 63
Helsinki 58
Los Angeles 58
Shenyang 49
Hebei 48
Kunming 47
Woodbridge 44
Tianjin 42
Rome 39
Munich 33
Changsha 31
Jiaxing 31
Grevenbroich 30
Norwalk 29
Hong Kong 26
Augusta 25
Moscow 25
Milan 20
Seattle 20
Dong Ket 18
Jinan 18
Toronto 18
Changchun 17
Lanzhou 17
San Mateo 17
Brussels 16
Hangzhou 16
Falls Church 15
Nuremberg 15
Brno 14
Frankfurt am Main 13
Shanghai 13
São Paulo 13
Guangzhou 11
Vienna 11
Amsterdam 10
Leawood 10
Pune 10
Council Bluffs 9
London 9
Caserta 8
Lappeenranta 8
Ningbo 8
Terni 8
Venice 8
Belo Horizonte 7
Brasília 7
Naples 7
Ottawa 7
Romola 7
Tappahannock 7
Tirana 7
Wuhan 7
Bologna 6
Kocaeli 6
Lodz 6
Taiyuan 6
Teramo 6
Zhengzhou 6
Cappelle sul Tavo 5
Curitiba 5
Fairfield 5
Florence 5
Fuzhou 5
Grugliasco 5
Hefei 5
Istanbul 5
Orange 5
Paris 5
Rio de Janeiro 5
Spoltore 5
Ancona 4
Baku 4
Cagliari 4
Campobasso 4
Chicago 4
Delhi 4
Houston 4
Totale 8.612
Salva come PNG Salva come JPEG
Nome #
Role of growth factors in the development of diabetic complications 131
Pentraxin 3 and platelet activation in obese patients after gastric banding 129
Postprandial hyperglycemia is a determinant of platelet activation in early type 2 diabetes mellitus 128
Platelet Count Does Not Predict Bleeding in Cirrhotic Patients: Results from the PRO-LIVER Study 127
Soluble CD40L in Mediterranean Spotted Fever: relation to oxidative stress and platelet activation 119
Enhanced lipid peroxidation and platelet activation in the early phase of type 1 diabetes mellitus: role of interleukin-6 and disease duration. 119
Long-term Positivity to SARS-CoV-2: A Clinical Case of COVID-19 with Persistent Evidence of Infection 116
Variability in the Recovery Rate of Platelet Cyclooxygenase Activity During Chronic Therapy With Low-Dose Aspirin in Type 2 Diabetes. 116
Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study 116
Oxidative-induced membrane damage in diabetes lymphocytes: effects on intracellular Ca2+ homeostasis 114
Thromboxane-dependent CD40 ligand release in type 2 diabetes mellitus 107
Significance of urinary 11-dehydro-thromboxane B2 in age-related diseases: Focus on atherothrombosis 107
Platelet Cyclooxygenase Inhibition by Low-Dose Aspirin Is Not Reflected Consistently by Platelet Function Assays. Implications for Aspirin "Resistance" 106
Association of low-grade inflammation and platelet activation in hypertensive patients with microalbuminuria 106
Neurocognitive impairment and suicide risk among prison inmates 106
In vivo thromboxane-dependent platelet activation is persistently enhanced in subjects with impaired glucose tolerance 106
Platelets and Diabetes 105
The Recovery of Platelet Cyclooxygenase Activity Explains Interindividual Variability in Responsiveness to Low-Dose Aspirin in Patients With and Without Diabetes. 103
Determinants of platelet activation in hypertensives with microalbuminuria. 102
Platelet cyclooxygenase inhibition by low-dose aspirin is not reflected consistently by platelet function assays. implications for aspirin 'resistance'. 101
Platelets and diabetes mellitus 101
Livelli circolanti di adiponectina e interleuchina-10 nell’obesità di tipo androide. 100
Effects of Liraglutide on Weight Loss, Fat Distribution, and β-Cell Function in Obese Subjects With Prediabetes or Early Type 2 Diabetes 100
Post-traumatic stress in pregnant women with primary cytomegalovirus infection and risk of congenital infection in newborns. 100
Cyclooxygenase-1 haplotype C50T/A-842G does not affect platelet response to aspirin 98
Arterial stiffness and sedentary lifestyle: Role of oxidative stress 98
Association between circulating adiponectin and interleukin-10 levels in android obesity: effects of weight loss. 97
Decreased plasma soluble RAGE in patients with hypercholesterolemia: effects of statins. 96
Circulating dickkopf-1 in diabetes mellitus: association with platelet activation and effects of improved metabolic control and low-dose aspirin. 96
Oxidative stress drivers and modulators in obesity and cardiovascular disease: from biomarkers to therapeutic approach. 96
The role of antileukotrienes in the treatment of asthma. 95
Cyclooxygenase-1 haplotype C50T/A-842G does not affect platelet response to aspirin. 95
Coagulation and infective endocarditis: sooner or later 94
Circulating CD40 ligand, Dickkopf-1 and P-selectin in HIV-infected patients 94
Determinants of increased cardiovascular disease in obesity and metabolic syndrome. 94
CD40 ligand and MCP-1 as predictors of cardiovascular events in diabetic patients with stroke. 93
Effects of atorvastatin and rosuvastatin on thromboxane-dependent platelet activation and oxidative stress in hypercholesterolemia. 91
Liraglutide improves memory in obese patients with prediabetes or early type 2 diabetes: a randomized, controlled study 91
The role of nitric oxide in the development of diabetic angiopathy. 90
Effects of vitamin E supplementation on intracellular antioxidant enzyme production in adolescents with type 1 diabetes and early microangiopathy. 90
Platelet activation in obesity and metabolic syndrome. 90
Decreased plasma soluble RAGE in patients with hypercholesterolemia: effects of statins. 90
A novel flow cytometric approach to distinguish circulating endothelial cells from endothelial microparticles: relevance for the evaluation of endothelial dysfunction 90
The deadly line linking sympathetic overdrive, dipping status and vascular risk: Critical appraisal and therapeutic implications 90
Thromboxane-dependent platelet activation in obese subjects with prediabetes or early type 2 diabetes: Effects of liraglutide-or lifestyle changes-induced weight loss 90
Circulating endothelial progenitor cells and residual in vivo thromboxane biosynthesis in low-dose aspirin-treated polycythemia vera patients 89
Atherothrombotic disease and the metabolic syndrome. 89
Mean platelet volume variation after biologic therapy in psoriasis and psoriatic arthritis. 89
A case of coinfection with SARS-COV-2 and Cytomegalovirus in the Era of Covid-19 89
Oxidative stress and thromboxane-dependent platelet activation in inflammatory bowel disease: Effects of anti-TNFα treatment 88
Determinants of thromboxane biosynthesis in patients with moderate to severe chronic kidney disease 88
Insulin resistance as a determinant of platelet activation in obese women. 87
Circulating endothelial progenitor cells and low-dose-aspirin-insensitive thromboxane biosynthesis in polycythemia rubra vera. 87
Soluble forms of RAGE in internal medicine. 87
Soluble forms of RAGE in human diseases: clinical and therapeutical implications. 86
Circulating Myeloid-Related Protein-8/14 is Related to Thromboxane-Dependent Platelet Activation in Patients With Acute Coronary Syndrome, With and Without Ongoing Low-Dose Aspirin Treatment. 85
Platelets as a source of CD40 ligand in type 2 diabetes mellitus 85
Effects of high-amount-high-intensity exercise on in vivo platelet activation: Modulation by lipid peroxidation and AGE/RAGE axis 85
Effects of irbesartan on intracellular antioxidant enzyme expression and activity in adolescents and young adults with early diabetic angiopathy 84
Determinants of the Variability in the Recovery Rate of Platelet Cyclooxygenase Activity during Chronic Therapy with Low-Dose Aspirin in Type 2 Diabetes 84
Decreased plasma soluble rage in patients with hypercholesterolemia: effects of statins. 83
LIGHT/TNFSF14 is increased in patients with type 2 diabetes mellitus and promotes islet cell dysfunction and endothelial cell inflammation in vitro 83
Prevention of atherothrombotic events in patients with diabetes mellitus: from antithrombotic therapies to new-generation glucose-lowering drugs 83
From Endothelium to Lipids, Through microRNAs and PCSK9: A Fascinating Travel Across Atherosclerosis 83
Determinants of thromboxane biosynthesis in rheumatoid arthritis: Role of RAGE and oxidant stress. 82
Duration of COVID-19: Data from an Italian Cohort and Potential Role for Steroids 82
Soluble RAGE in type 2 diabetes: association with oxidative stress. 80
Circulating endothelial progenitor cells and residual in vivo thromboxane biosynthesis in low-dose aspirin-treated polycythemia vera patients. 79
Metabolic Syndrome: Sex-Related Cardiovascular Risk and Therapeutic Approach 79
Increased Vascular Endothelial Growth Factor Serum Concentrations May Help to Identify Patients with Onset of Type 1 Diabetes during Childhood at risk for Developing Persistent Microalbuminuria 79
Relative chemokine and adhesion molecule expression in Mediterranean spotted fever and African tick bite fever 79
Determinants of platelet activation in hypertensives with microalbuminuria. 78
Effectiveness of Montelukast versus Budesonide on quality of life and bronchial reactivity in subjects with mild-persistent asthma 78
Circulating MRP 8/14 is Associated with Thromboxane Dependent Platelet Activation in NSTEMI Patients: Effect of Aspirin Treatment 77
Enhanced soluble CD40 Ligand is responsible for endothelial dysfunction and monocyte activation in patients with diabetes mellitus. Effect of improved metabolic control. 77
Postprandial hyperglycemia is an important determinant of platelet activation. evidence from biochemical measurements and pharmacological intervention with acarbose 77
Oxidative stress in chronic vascular disease: From prediction to prevention 77
The left atrial appendage: from embryology to prevention of thromboembolism 77
Thrombin as a common downstream target blocking both platelet and monocyte activation 76
Thromboxane and prostacyclin biosynthesis in heart failure of ischemic origin: effects of disease severity and aspirin treatment. 76
24-months follow-up to assess the efficacy and tolerability of evolocumab in a young patient with chronic and progressive ischemic arteriopathy 76
Aterosclerosi ed aterosclerosi accelerata: ruolo e meccanismi dell’immunoflogosi. 75
Association between PAI-1 and Oxidative Stress in Android Obesity 75
Attivazione piastrinica e stress ossidativo in vivo nell’artrite reumatoide. 75
Oxidative stress-related mechanisms affecting response to aspirin in diabetes mellitus 75
The Coxib case: Are EP receptors really guilty? 75
Antiplatelet Agents. Thromboxane receptors antagonists and/or synthase inhibitors 74
Postprandial hyperglycemia is an important determinant of platelet activation in early type 2 diabetes mellitus. Evidence from biochemical measurements and pharmacological intervention with acarbose. 74
Homocysteine and education but not lipoprotein (a) predict estimated 10-year risk of cardiovascular disease in blood donors: a community based cross-sectional study 74
COVID-19 and RAS: Unravelling an Unclear Relationship 74
Oxidant stress as a major determinant of platelet activation in invasive breast cancer 74
Association between enhanced soluble CD40 ligand and platelet activation in hypertensives with microalbuminuria. 74
CD40 ligand and MCP-1 levels as predictors of cardiovascular events in lacunar and non-lacunar strokes. 73
Effects of atorvastatin and rosuvastatin on thromboxane-dependent platelet activation and oxidative stress in hypercholesterolemia. 73
Nutraceuticals in diabetes and metabolic syndrome. 72
Decreased plasma levels of soluble receptor for advanced glycation end products in type 2 diabetes mellitus: association with oxidative stress and metabolic control. 72
Plasma levels of soluble CD36, platelet activation, inflammation, and oxidative stress are increased in type 2 diabetic patients 72
Aspirin, platelets, and cancer: The point of view of the internist. 72
Unveiling the inflammatory face of antiplatelet drugs. 71
Effects of Acarbose on in Vivo Markers of Oxidative Stress and Platelet Activation in Early Type 2 Diabetes 71
Totale 8.981
Salva come PNG Salva come JPEG
Categoria #
all - tutte 67.919
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 67.919
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020257 0 0 0 0 0 0 0 0 0 0 235 22
2020/20211.105 191 17 202 20 58 242 31 28 102 140 38 36
2021/20221.005 29 26 10 175 76 43 39 75 97 55 112 268
2022/20232.957 232 426 180 284 276 596 160 240 377 36 86 64
2023/20241.741 104 44 119 51 131 551 363 107 39 51 25 156
2024/20252.887 242 703 577 88 92 172 169 179 355 178 132 0
Totale 15.048